On the stock market since 2020, it operates in the world of health and science. It has 129 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Red columns mark years that ended in a loss.
If every debt were paid off today, $525.2M would still be left in the vault — a solid cushion for hard times.
The stock trades 26% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 43% — still a thick cushion, though costs have been eating into it lately.
There is $525.2M in the vault; even if every debt were paid off, $525.2M would remain.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, PNT sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: PNT is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.